ProQR Therapeutics N.V.

PRQR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$11-$12-$10-$9
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$3-$1-$7-$1
Other Non-Cash$1$0-$0-$1
Operating Cash Flow-$12-$11-$16-$9
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$3
Investing Cash Flow-$0-$0-$0-$3
Financing Activities
Debt Repay.-$0-$0-$1-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$72
Financing Cash Flow-$0-$0-$1$71
Forex Effect-$0-$1-$0$1
Net Chg. in Cash-$13-$13-$17$60
Supplemental Information
Beg. Cash$120$132$149$89
End Cash$107$120$132$149
Free Cash Flow-$12-$12-$16-$9
ProQR Therapeutics N.V. (PRQR) Financial Statements & Key Stats | AlphaPilot